as seen on

FB logo Darker

All general sessions were streamed LIVE on Facebook

GENERAL SESSIONS – DAY 1

Trigriluzole: A Phase 2/3 Randomized Controlled Trial in Patients with Spinocerebellar Ataxia Robert Berman, MD
Clinical vs. Basic Science Research – Harry Orr, PhD and George (Chip) Wilmot, MD, PhD
NAF Update – Bill Sweeney, NAF President
Living with Ataxia – Moderator: Kyle Bryant; Panelists: Jonas Cepkauskas, Cathy DeCrescenzo, and Linda Snider, MD
Barriers to Exercise – Jennifer Millar, MS, PT and Jennifer Keller, MSPT

GENERAL SESSIONS – DAY 2

FRDA and Other Childhood Ataxias – David Lynch, MD, PhD
Genetic Testing – You Need to Get Tested: Here’s Why – Jeremy Schmahmann, MD
Ataxia Investigators Meeting (AIM) Highlights – Gülin Öz , PhD and Albert LaSpada, MD, PhD, FACMG
Management of Ataxia – Moderator: John W. Day, MD, PhD; Panelists: Amanda Gallagher, MA, CCC-SLP, Jennifer Keller, MSPT, and Liana Rosenthal, MD
Home Safety Based Modifications – Jessica Wilchinski, MA, OT R/L and Marlena Casey, OT R/L, CLT

FEATURED SPEAKERS

Sponsors